Ausschreibungen Vertraege Organisationen
Anmelden

Vertragslandschaft — Astellas Pharma GmbH

164.813
Vertraege
53.682
Auftragnehmer
21 Vertraege gefunden (Seite 1 von 1)
Tabelle Nach Auftraggeber Nach Gewinner
▶ Astellas Pharma GmbH
6 Vertraege 0 exklusiv · 1 Rahmen 435.002 EUR
▶ AOK-Systems GmbH
4 Vertraege 435.001 EUR
Deutschland-Stuttgart: Arzneimittel
16.10.2019 · 1 Los ted_europa
221.000 EUR
Deutschland-Erfurt: Arzneimittel
24.08.2020 · 1 Los ted_europa
214.000 EUR
Deutschland-Bremen: Arzneimittel
08.10.2018 · 1 Los ted_europa
1 EUR
Deutschland-Eisenberg: Arzneimittel
10.07.2019 · 1 Los ted_europa
0 EUR
▶ Deutsche Rentenversicherung Knappschaft-Bahn-See
1 Vertrag 1 EUR
Deutschland-Bochum: Arzneimittel
05.10.2019 · 1 Los ted_europa
1 EUR
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ BERLIN-CHEMIE AG
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ BG ALIUD / STADAPHARM GbR
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ DR KADE Pharmazeutische Fabrik GmbH
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ Denk Pharma
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ ETHYPHARM GmbH
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ GALENpharma GmbH
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ HEXAL AG
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ HIKMA PHARMA GMBH
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ LEO Pharma GmbH
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ Micro Labs GmbH
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ ORION Pharma GmbH
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ OmniVision
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ Phoenix Labs
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ Puren Pharma GmbH & Co. KG
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ Recordati Pharma
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ Viatris Healthcare GmbH, Zweigniederlassung Bad Homburg
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ ViivHealthcare
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ axunio Pharma GmbH
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ neuraxpharm Arzneimittel GmbH
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.
▶ ratiopharm GmbH
1 Vertrag 0 exklusiv · 1 Rahmen
▶ GWQ ServicePlus AG
1 Vertrag
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag 21 Auftragnehmer 20.01.2026 · 01.04.2026–30.06.2028 · 52 Lose ted_europa
k.A.